Biotechnology Industry












Overview Of Biotechnology Sector

In 2006, India was ranked 3rd in the South-Eastern Asia region after Korea and Japan on the basis of number of biotech companies (Ernst and Young). India has about 280 companies in biotech sector. Biocon was
ranked India's largest biotech company and Rasi was the top Bt cotton producer in the group.

With a record growth rate of about 37.42%, Indian biotech industry has achieved market value of US$ 1.45 billion (Rs. 6521 crore). It has been growing at the pace of 35-40% for the last three
years and is estimated to grow to US$ 5 billion by 2010. The immense potential of the sector is clearly visible from its growth rate. Growing numbers of research laboratories, pool of qualified scientific talent, widening institutional
network, vibrant clinical potential and fast growing pharma sector are the important growth stimulants.

Sector Outlook
Classification of Sector
SWOT Analysis
Evolution of Biotechnology

India's ecological and population diversity has played a key role in the developments in the areas of research and drug discovery in biotech sector. Government is also supporting the biotech sector by providing financial and non-financial incentives at central and state level.

Although Indian biotech industry is just 1.1% of the world biotech industry, India is soon going to become a prominent player. Today India is the favorite destination not only for biotech products, pharmaceuticals and diagnostics but also for outsourcing of contract research and clinical trials.

According to the BioSpectrum-ABLE survey report in 2006:

  • BioPharma sector crossed the $1 billion (Rs 4,475 crore) mark, driven by exports worth Rs 2495.24 crore.
  • BioAgri sector recorded the highest growth.
  • The industry has shown 81 percent growth rate.
  • The popularity of Bt cotton helped the BioAgri sector to grow to Rs 598 crore from Rs 330 crore
  • Serum has shown Rs 703 crore in sales and is ahead of Biocon Ltd by Rs 15 crore.